To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects

NCT06468579 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne
Alopecia

Interventions

DRUG: GT20029
DRUG: GT20029 matching placebo

Sponsor

Suzhou Kintor Pharmaceutical Inc,